Q2QLC5 AF NFT

Cystic fibrosis transmembrane conductance regulator

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeietrnnsxydblnm6ohgjfmfilspxfcflbojtoi7ek27nrajtpsoyv4/metadata.json
IPFS of structure file: 
bafybeiekeim6ddv2rce2hy4falnmnq3xyhuoz6mmwizztcundrfmpkaeje/AF-Q2QLC5-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x8e3a917A16E8163577aA515EA010E513A6d710df
First NFT owner address (bech32): 
genesis13cafz7skaqtr2aa22902qy89zwndwyxlyt39qh
Current NFT ID #58963 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
58963
Accession (UniProt):
Q2QLC5
Name::
Cystic fibrosis transmembrane conductance regulator
Experimental Method:
Predicted structure
Sequence source:
Carollia perspicillata

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q2QLC5 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q2QLC5|CFTR_CARPS Cystic fibrosis transmembrane conductance regulator OS=Carollia perspicillata OX=40233 GN=CFTR PE=3 SV=1 MQRSPLEKASVVSKLFFSWTRPILKKGYRQRLELSDIYQIPSADSADNLSEILEREWDRELASKKNPKLINALRRCFFWRFMFYGILLYLGEVTKAVQPLLLGRIIASYDPDNKVERSIAIYLGIGLCLLFILRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVTLLMGLLWELLQASAFYGLAALIVVALLQAFLGRMMMKYRDQRAGKINERLVITSEIIENIQSVKAYCWEEAMEQMIENLRKTELKLTQKAAYVRYVNSSGFFASGFFVVLFSVLPYLLNEGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSIGAINKIQDFLQKQEFKTLEYNLTTTEVVMENVTAFWDEGFGELFENAKQNSKNRNISNSDNSLFFSNFSLLGTPVLRDINFQIERGQLLAIAGSTGAGKTSLLMMLLGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVCYDEYRYRSVIKACQLEEDISKFAEKDNVVLGEGGLTLSGGQRARICLARAVYKDADLYLLDSPFGHLDVLTEKQIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLRPDFHSKLMGYDSFDQFSAERRNSILTETLRRFSLEGDAAIPWNETKKQSFKQTGEFGEKRKNSILNPINSAKKFSVVQKTPLQMNGIEEDSEEPSERRLSLVPDSEQGEAILPRSNVINTGPTFQKRRRQSVLNLMTHSSVNQCQIIHQKTAPSTRKMSLAPQGDLAEMDIYSRRLSQGSGLEISEEINEEDLKECFFDDMESIPTVTTWNTYLRYVTAHKSLSFVLIWCLVLFLAEVAAFLVLLWHFKEKPPQDRGNSTGSTNSSNAFIVTNTSHFYLFYIYVGVADSLFALGFIRGLPLVHSLITVSKILHHKMLHSVLHAPMSTLNMLKAGEILNRFSKDTAILDDLLPLTIFDFIQLALIVIGAIAVVSVLQPYIFLATVPVITAFITLRAYFLPTSQQLKQLESEGRSPIFTHLVTSLRGLWTLRAFGRQPYFEALFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAMNSSIDVDSLMRSVSRVFKFIDMPTEESKSTKLIKPSKDDKLTKVMIIENQHVKKDDLWPLGGQMTIKNLIAKYTDNGNAILENISFSISPGQRVGLLGRTGSGKSTLLSALLRLLNTEGEIQIDGVSWDSVTLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWNDEEIWKVADEVGLRSVIEQFPGKLDFVLLDGGFVLSHGHKQLLCLARSVLSKAKILLLDEPSAHLDPITYQIIRRTLKQAFADCTVILSEHRIEAMLECQQFLVIEENKVRQYDSLQKLLSEKILFQQAMSPLDRLKLLPHRNSSRHKSQSKISALKEETEEEVQETRL